Drafzin Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Fluoxetine HCl

Indications/Uses

Treatment of depression due to various origins eg, endogenous, neurotic & reactive depressions. Decreases incidence of bulimic attacks; treatment of associated symptoms eg, wt loss (self-induced vomiting, abuse of laxatives). Treatment of obsessive-compulsive disorders which are identified by persisting obsession, thoughts, perception &/or repeated intentional marked compulsive behaviour.

Click to view Drafzin detailed prescribing information

Dosage/Direction for Use

Adult Depression 20 mg daily. Max: 80 mg daily. Doses >20 mg should be given in 2 divided doses (eg, morning & evening). Obsessive-compulsive disorder Initially 20 mg daily, may be increased to 60 mg daily after several wk. Bulimia nervosa 60 mg daily. Elderly & patient w/ low body wt Max of 60 mg.

Click to view Drafzin detailed prescribing information

Overdosage

View Drafzin overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Concomitant use w/ MAOIs.

Click to view Drafzin detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Drafzin detailed prescribing information

Special Precautions

Anxiety or marked sleeping difficulties at the start of therapy. Patients w/ existing or history of epilepsy; severe hepatic & renal impairment; diabetes; patients taking drugs acting on CNS; patients w/ suicidal tendencies. Discontinue if rash & possible allergic events occur. May cause significant wt loss. May impair ability to drive or operate machinery. Pregnancy (especially during 1st trimester) & lactation. Childn.

Click to view Drafzin detailed prescribing information

Use In Pregnancy & Lactation

Click to view Drafzin detailed prescribing information

Adverse Reactions

Chills & fever, fatigue, asthenia, face edema; nausea & vomiting, disturbance of appetite, diarrhea; headache, nervousness, agitation, visual disturbances, insomnia, anxiety, dizziness; UTI, sexual dysfunction, painful menstruation; dyspnea, bronchitis; infrequently, asthma, hiccup, hyperventilation; acne, alopecia, dry skin, eczema; back, joint & muscle pain.

Click to view Drafzin detailed prescribing information

Drug Interactions

Increased risk of severe adverse events w/ MAOIs. May interfere w/ tryptophan, TCAs, carbamazepine, haloperidol, phenothiazine, other CNS active drugs eg, lithium.

Click to view Drafzin detailed prescribing information

Storage

View Drafzin storage conditions for details to ensure optimal shelf-life.

Description

View Drafzin description for details of the chemical structure and excipients (inactive components).

Action

View Drafzin mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antidepressants

ATC Classification

N06AB03 - fluoxetine ; Belongs to the class of selective serotonin reuptake inhibitors. Used in the management of depression.

Regulatory Classification

Presentation/Packing

Form

Drafzin cap 20 mg

Packing/Price

30's (P580.36/box, P19.45/cap)

Drafzin

fluoxetine

Manufacturer:

Laboratorios Silesia

Distributor:

JF Draf